August 2026– date –
-
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
Bioreactor-Based Transient Transfection with HEK 293-F Cells Unlocks Large-Scale HPV VLP Production
MDPI Switzerland Overview A recent study demonstrates a significant advance in biopharmaceutical manufacturing, achieving highly efficient, large-scale production of HPV16 L1/L2 chimeric virus-like particles (VLPs). By leveraging transie... -
Biopharma’s Evolving Blueprint: AGC Biologics Expands Global Capacity, Enzene Drives Continuous Manufacturing Adoption
Pharma Manufacturing USA Overview This news digest highlights several pivotal developments in the biopharmaceutical manufacturing sector, showcasing an industry-wide acceleration towards enhanced capacity and technological innovation. Ke... -
Biomanufacturing Reorients: Geopolitical Forces Drive Sourcing to Qualified, Regional Capacity, with Cellares Pioneering IDMO Smart Factories
Pharma's Almanac USA Overview Geopolitical forces are profoundly reshaping biomanufacturing procurement, driving a surge in demand for 'qualified capacity' – providers with specialized expertise and robust regulatory compliance. This shi... -
Cracking the Cost Code: Cellares’ Automated Platform Targets 75% Reduction in CAR-T Manufacturing, Pinpointing Viral Vectors as Key Driver
IntuitionLabs USA Overview A new analysis highlights viral vectors as the primary cost driver in CAR-T cell therapy manufacturing, prompting an urgent need for more efficient production. While existing closed-system platforms offer incre... -
Cell Therapy Consumables Market Set for $7.53 Billion Surge by 2032, Fueled by Automation and Closed Systems
Credence Research India Overview A new report from Credence Research projects the global cell therapy consumables market will reach $7.53 billion by 2032. This significant growth is primarily driven by the expanding adoption of advanced ... -
AGC Biologics: Job Posting Reveals Broad Biomanufacturing Scope, Spanning Proteins to Gene Therapies
Myworkdayjobs.com USA Overview A recent student assistant job posting from AGC Biologics has inadvertently showcased the company's remarkably extensive Contract Development and Manufacturing Organization (CDMO) capabilities. The company ... -
Miltenyi Biotec’s CliniMACS Prodigy® Automates TIL Expansion, Paving Way for Scalable Cancer Immunotherapy
Bioprocess Online Germany Overview Miltenyi Biotec is advancing the automated expansion of tumor-infiltrating lymphocytes (TILs) using its GMP-compliant CliniMACS Prodigy® platform. This system addresses critical challenges in scaling up... -
Allogeneic Cell Therapy Manufacturing: Broad Applicability, Scalability, and Automation Driving Future Advances
Industry Informational Article USA Overview This article provides a comprehensive overview of allogeneic cell therapy manufacturing, highlighting its advantages over autologous approaches, including broader applicability, superior scalab... -
Liv Hospital Highlights Off-the-Shelf Allogeneic CAR-T Manufacturing for Enhanced Accessibility via Standardized Donor Cells
Liv Hospital Turkey Overview Liv Hospital is championing the development of allogeneic CAR-T cell manufacturing as an 'off-the-shelf' solution, leveraging standardized donor cells to significantly improve treatment accessibility. This ad...
